• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchImmuPharma
    Picture of ImmuPharma logo

    IMM — ImmuPharma Share News

    3.70p0.000.00%
    gb flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    • Market Cap
      £23.14m
    • Enterprise Value
      £22.44m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • IMM Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    IMM Dividends
    • Immupharma At Bio: EUROPE SPRING 2024

      14/03/2024 07:00
    • Financial, Business and Portfolio Develop't Update

      06/03/2024 07:00
    • Holding(s) in Company

      28/12/2023 13:35
    • Holding(s) in Company

      19/12/2023 14:50
    • Holding(s) in Company

      13/09/2023 15:47
    • Holding(s) in Company

      06/09/2023 13:53
    • Brief: Immupharma HY Diluted Loss Per Share 0.25 Pence

      31/08/2023 07:20
    • WRAP Retail Offer for up to £0.5m

      31/08/2023 07:02
    • Subscription to raise £1.35m; Sharing Agr, RPT

      31/08/2023 07:01
    • Interim results

      31/08/2023 07:00
    • Brief: ImmuPharma Announces Extension Of Warrants In Incanthera

      21/08/2023 07:20
    • Directorate Change

      11/08/2023 12:04
    • UK's ImmuPharma jumps as Lupuzor Phase 2/3 clinical trial set to start in H2

      19/06/2023 08:23
    • Lupuzor Update

      19/06/2023 07:00
    • IMM RNS Posting of RA and Notice of AGM 30 June 23

      06/06/2023 07:00
    • Brief: Immupharma Plc Announces Positive Guidance From FDA For IND Application Of P140 In CIDP

      18/05/2023 07:34
    • UK's ImmuPharma drops on annual loss, lower year-end cash

      11/05/2023 09:12
    • Brief: Immupharma PLC Reports FY Loss For Period Of £3.8M

      11/05/2023 07:46
    • Final Results

      11/05/2023 07:00
    • Holding(s) in Company

      10/05/2023 13:56
    Previous12345Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.